Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial
Pfizer
Kristian Reich; Jacob P Thyssen; Andrew Blauvelt; Kilian Eyerich; Weily Soong; Zakiya P Rice; H Chih-Ho Hong; Norito Katoh; Fernando Valenzuela; Marco DiBonaventura; Tamara A Bratt; Fan Zhang; Claire Clibborn; Ricardo Rojo; Hernan Valdez; Urs Kerkmann